from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0261c/narK3

LFCtreatmentdescriptionclass of inhibitor

-0.544

Amikacinug/mL Amikacintranslation

0.021

Cap5-10ug/mL Capreomycintranslation

0.582

Rox10-50 ug/mL Roxithromycintranslation

0.697

SM2-5 ug/mL Streptomycintranslation

-0.220

Tet5-10 ug/mL Tetracyclinetranslation

0.923

Rif0.2-5ug/mL Rifampicintranscription

0.062

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.268

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.171

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.023

CPZ10-50 ug/mL Chlorpromazinerespiration

0.456

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.077

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.866

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.494

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.631

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.171

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.376

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.107

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.738

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.048

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.318

Nigericin50 uM Nigericinrespiration

0.360

TRC10-150 ug/mL Triclosanrespiration

0.951

TRZ10-25 ug/mL Thioridazinerespiration

0.474

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.437

menadione6-10 ug/mL Menadionerespiration

-0.295

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.087

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.191

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.325

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.213

NRP_1Non-replicating persistence stage 1dosRassociated

-0.049

Amp0.2mg/mL AmpicillincellWall

-0.048

Cephalexin20-100 ug/mL CephalexincellWall

0.060

Cerulenin0.32-5 ug/mL CerulenincellWall

0.378

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.281

EMB10-20 ug/mL EthambutolcellWall

0.034

Eta12-40 ug/mL EthionamidecellWall

-0.347

INH0.2-0.4 ug/mL IsoniazidcellWall

0.124

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.109

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.241

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.006

BZA0.12 mg/mL BenzamidearomaticAmides

-0.525

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.559

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.113

H2O24 mM hydrogen peroxideDNAdamaging

0.062

Levo10 ug/mL LevofloxacinDNAdamaging

-0.324

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.165

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.103

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.049

UVUV-irradiationDNAdamaging

0.507

ARP41-4 ug/mL Antitubercular compound ARP4?

0.314

Antimycin12.5-50 ug/mL Antimycin A?

0.058

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.110

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.398

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.205

PA8240.2-2 ug/mL PA-824?

0.082

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.065

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.365

Verapamil50 uM Verapamil?

0.194

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.110

methoxatin10-20 ug/mL Methoxatin?